Cargando…
Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new
For metastatic soft tissue sarcoma (STS) patients not eligible for surgery, systemic treatments, including standard chemotherapy and newer biological compounds, still play the most relevant role in the management of the disease. An anthracycline and alkylating agent combination has formed the corner...
Autores principales: | Frezza, Anna Maria, Stacchiotti, Silvia, Gronchi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455204/ https://www.ncbi.nlm.nih.gov/pubmed/28571564 http://dx.doi.org/10.1186/s12916-017-0872-y |
Ejemplares similares
-
Highlights in soft tissue sarcomas and gastrointestinal stromal tumours (GIST) trials reported at ASCO 2017 Annual Meeting
por: Frezza, Anna Maria, et al.
Publicado: (2017) -
Staging Systems and Nomograms for Soft Tissue Sarcoma
por: Danieli, Maria, et al.
Publicado: (2023) -
New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy
por: Pavlidis, Efstathios T, et al.
Publicado: (2023) -
2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma
por: Frezza, Anna Maria, et al.
Publicado: (2018) -
Advanced imaging and artificial intelligence for Barrett's esophagus: What we should and soon will do
por: Spadaccini, Marco, et al.
Publicado: (2022)